Centro Nacional de Salud Pública, Instituto Nacional de Salud, Lima, Perú.
Facultad de Salud Pública y Administración (GA, AGL), Universidad Peruana Cayetano Heredia, Lima, Perú.
Sci Rep. 2023 Mar 16;13(1):4356. doi: 10.1038/s41598-023-29773-9.
Despite widespread vaccination, Bordetella pertussis continues to cause pertussis infections worldwide, leaving infants at the highest risk of severe illness and death, while people around them are likely the main sources of infection and rapidly spread the disease. Rapid and less complex molecular testing for the specific and timely diagnosis of pertussis remains a challenge that could help to prevent the disease from worsening and prevent its transmission. We aimed to develop and validate a colorimetric loop-mediated isothermal amplification (LAMP) assay using a new target uvrD_2 informed by the pangenome for the specific and early detection of B. pertussis. Compared to that of multitarget quantitative polymerase chain reaction (multitarget qPCR) using a large clinical DNA specimen (n = 600), the diagnostic sensitivity and specificity of the uvrD_2 LAMP assay were 100.0% and 98.6%, respectively, with a 99.7% degree of agreement between the two assays. The novel colorimetric uvrD_2 LAMP assay is highly sensitive and specific for detecting B. pertussis DNA in nasopharyngeal swabs and showed similar diagnostic accuracy to complex and high-cost multitarget qPCR, but it is faster, simpler, and inexpensive, which makes it very helpful for the reliable and timely diagnosis of pertussis in primary health care and resource-limited settings.
尽管广泛接种疫苗,但博德特氏菌仍在全球范围内导致百日咳感染,使婴儿面临最严重疾病和死亡的风险,而他们周围的人很可能是感染的主要来源,并迅速传播疾病。快速且不那么复杂的分子检测对于特定且及时的百日咳诊断仍然是一个挑战,这有助于防止疾病恶化并阻止其传播。我们旨在开发和验证一种使用新目标 uvrD_2 的比色环介导等温扩增 (LAMP) 检测法,该目标由泛基因组提供,用于特异性和早期检测博德特氏菌。与使用大型临床 DNA 标本的多靶点定量聚合酶链反应 (multitarget qPCR) 相比(n=600),uvrD_2 LAMP 检测法的诊断灵敏度和特异性分别为 100.0%和 98.6%,两种检测方法的一致性为 99.7%。新型比色 uvrD_2 LAMP 检测法对鼻咽拭子中博德特氏菌 DNA 的检测具有高度敏感性和特异性,与复杂且昂贵的多靶点 qPCR 具有相似的诊断准确性,但它更快、更简单且成本更低,这对于在初级保健和资源有限的环境中可靠且及时地诊断百日咳非常有帮助。